Expert Interview
A Second View: Discussing the recent FDA approval for Radicava ORS (edaravone) - orally administered version of Radicava on the treatment landscape of ALS
Ticker(s): MTPA, CLNNDr. Raymond P. Roos, MD
Institution: University of Chicago
-
Marjorie and Robert E. Straus Professor of Neurology & Director, Amyotrophic Lateral Sclerosis/Motor Neuron Disease Clinic at the University of Chicago.
-
Currently manages about 150 patients with ALS and is familiar with literature on AMX0035.
-
Research studies use molecular techniques to better understand the pathogenesis of MS and ALS. His lab uses viruses and transgenic mouse models in order to clarify the mechanisms by which mutant genes kill the target neurons.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
